Insights derived from the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) trials

This publication has 31 references indexed in Scilit:

• Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction.
  Circulation, 1988
• Characteristics and outcome of patients in whom reperfusion with intravenous tissue-type plasminogen activator fails: results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) I trial.
  Circulation, 1988
• THROMBOLYSIS WITH TISSUE PLASMINOGEN ACTIVATOR IN ACUTE MYOCARDIAL INFARCTION: NO ADDITIONAL BENEFIT FROM IMMEDIATE PERCUTANEOUS CORONARY ANGIOPLASTY
  The Lancet, 1988
• A Randomized Trial of Immediate versus Delayed Elective Angioplasty after Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction
  New England Journal of Medicine, 1987
• Coronary arterial thrombolysis with low-dose synergistic combinations of recombinant tissue-type plasminogen activator (rt-PA) and recombinant single-chain urokinase-type plasminogen activator (rscu-PA) for acute myocardial infarction
  The American Journal of Cardiology, 1987
• Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.
  Circulation, 1987
• Coronary thrombolysis in patients with acute myocardial infarction by intravenous infusion of synergic thrombolytic agents
  American Heart Journal, 1986
• Synergism of thrombolytic agents in vivo.
  Circulation, 1986
• Enhancement of thrombolysis with tissue-type plasminogen activator by pretreatment with heparin.
  Circulation, 1986
• Interaction of heparin with plasminogen activators and plasminogen: effects on the activation of plasminogen
  Biochemistry, 1986